Clinical Trial Update: Comparison of BCG RIVM and Russian Strains for Treating Non-Muscle-Invasive Bladder Cancer (NMIBC) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing BCG RIVM with Russian-strain BCG for non-muscle-invasive bladder cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Bacillus Calmette-Guérin (RIVM strain) (Bacillus Calmette-Guérin)
• Bacillus Calmette-Guérin (Russian strains) (Bacillus Calmette-Guérin)

Snippet

Sponsor: Ankara University | Conditions: Non Muscle Invasive Bladder Cancer | Phase 4 | Status: COMPLETED